BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price…
Insider buying and selling since 2013
BAKER BROS. ADVISORS LP bought shares on the open market in 11 different years since 2013 across 12 companies. Sales in 2 of the 14 years since 2013.
BAKER BROS. ADVISORS LP reported 320 open-market purchases and 6 sales since 2013; purchases in 11 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 82×82 trades | — |
| 2025 | 80×80 trades | 2×2 trades |
| 2024 | 12×12 trades | 4×4 trades |
| 2023 | 24×24 trades | — |
| 2022 | 30×30 trades | — |
| 2021 | 1×1 trade | — |
| 2020 | 16×16 trades | — |
| 2018 | 2×2 trades | — |
| 2017 | 25×25 trades | — |
| 2016 | 24×24 trades | — |
| 2013 | 24×24 trades | — |
Insider at 12 companies
- Kodiak Sciences KOD2020–2026 · 111 purchases, 0 sales
- Madrigal Pharmaceuticals MDGL2023–2025 · 78 purchases, 0 sales
- Entrada Therapeutics TRDA2022–2025 · 34 purchases, 0 sales
- Beone Medicines ONC2017–2025 · 4 purchases, 6 sales
- Celcuity CELC2025 · 4 purchases, 0 sales
- Immunocore Holdings IMCR2025 · 4 purchases, 0 sales
- Kymera Therapeutics KYMR2025 · 2 purchases, 0 sales
- Bicycle Therapeutics BCYC2024 · 10 purchases, 0 sales
- Kala Bio KALA2024 · 2 purchases, 0 sales
- Neurogene NGNE2016–2017 · 44 purchases, 0 sales
- Incyte INCY2017 · 3 purchases, 0 sales
- Acadia Pharmaceuticals ACAD2013 · 24 purchases, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about BAKER BROS. ADVISORS LP's trades
Has BAKER BROS. ADVISORS LP bought shares on the open market?
BAKER BROS. ADVISORS LP bought shares on the open market in 11 different years since 2013 across 12 companies. Sales in 2 of the 14 years since 2013.
When did BAKER BROS. ADVISORS LP last buy or sell shares?
In SEC filings since 2013: the latest open-market purchase is from 2026; the latest open-market sale is from 2025.
Which companies has BAKER BROS. ADVISORS LP traded as an insider?
12 companies: Kodiak Sciences (KOD, 2020–2026), Madrigal Pharmaceuticals (MDGL, 2023–2025), Entrada Therapeutics (TRDA, 2022–2025), Beone Medicines (ONC, 2017–2025), Celcuity (CELC, 2025) and others.